Schwab Charles Investment Management Inc. boosted its position in Cooper Companies, Inc. (The) (NYSE:COO) by 5.6% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 244,686 shares of the medical device company’s stock after buying an additional 13,004 shares during the period. Schwab Charles Investment Management Inc. owned 0.50% of Cooper Companies, Inc. (The) worth $58,583,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently modified their holdings of COO. YorkBridge Wealth Partners LLC raised its stake in Cooper Companies, Inc. (The) by 18.5% in the first quarter. YorkBridge Wealth Partners LLC now owns 520 shares of the medical device company’s stock worth $105,000 after buying an additional 81 shares during the last quarter. Archford Capital Strategies LLC raised its stake in Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock worth $135,000 after buying an additional 363 shares during the last quarter. Penserra Capital Management LLC raised its stake in Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock worth $156,000 after buying an additional 68 shares during the last quarter. Visionary Asset Management Inc. bought a new stake in Cooper Companies, Inc. (The) during the second quarter worth approximately $201,000. Finally, Pacer Advisors Inc. raised its stake in Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock worth $170,000 after buying an additional 31 shares during the last quarter. Institutional investors own 96.09% of the company’s stock.

Shares of Cooper Companies, Inc. (NYSE:COO) opened at 250.83 on Friday. The stock’s 50 day moving average price is $246.71 and its 200 day moving average price is $220.95. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The stock has a market capitalization of $12.25 billion, a price-to-earnings ratio of 37.61 and a beta of 0.61.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its quarterly earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The firm had revenue of $522.40 million during the quarter, compared to analysts’ expectations of $520.71 million. During the same quarter in the previous year, the business earned $2.05 earnings per share. The company’s revenue was up 8.0% on a year-over-year basis. Analysts expect that Cooper Companies, Inc. will post $9.64 EPS for the current year.

The firm also recently declared a semiannual dividend, which was paid on Monday, August 7th. Stockholders of record on Friday, July 21st were paid a $0.03 dividend. This represents a dividend yield of 0.02%. The ex-dividend date was Wednesday, July 19th. Cooper Companies, Inc. (The)’s dividend payout ratio is currently 0.90%.

TRADEMARK VIOLATION WARNING: This story was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/09/01/schwab-charles-investment-management-inc-purchases-13004-shares-of-cooper-companies-inc-the-coo.html.

COO has been the subject of a number of analyst reports. BMO Capital Markets reissued an “outperform” rating and issued a $255.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Jefferies Group LLC reissued a “buy” rating and issued a $250.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Zacks Investment Research lowered Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Thursday, June 22nd. Stifel Nicolaus increased their price target on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, June 2nd. Finally, Piper Jaffray Companies increased their price target on Cooper Companies, Inc. (The) to $265.00 and gave the company an “overweight” rating in a research report on Wednesday, July 19th. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Cooper Companies, Inc. (The) presently has an average rating of “Buy” and a consensus price target of $242.33.

In other news, CEO Paul L. Remmell sold 9,294 shares of the business’s stock in a transaction on Friday, July 14th. The stock was sold at an average price of $248.46, for a total value of $2,309,187.24. Following the completion of the transaction, the chief executive officer now owns 6,186 shares in the company, valued at $1,536,973.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stanley Md Zinberg sold 816 shares of the business’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $243.14, for a total value of $198,402.24. The disclosure for this sale can be found here. Insiders sold 67,331 shares of company stock valued at $16,400,454 in the last 90 days. Company insiders own 1.60% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.